Pages that link to "Q37090054"
Jump to navigation
Jump to search
The following pages link to From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage. (Q37090054):
Displaying 50 items.
- The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection (Q26829884) (← links)
- Proposal of Dual Inhibitor Targeting ATPase Domains of Topoisomerase II and Heat Shock Protein 90 (Q26997981) (← links)
- Pharmacological actions of multi-target-directed evodiamine (Q27011404) (← links)
- Small Molecule Inhibitors to Disrupt Protein-protein Interactions of Heat Shock Protein 90 Chaperone Machinery (Q27022376) (← links)
- Network pharmacology: the next paradigm in drug discovery (Q28297997) (← links)
- Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs (Q28305100) (← links)
- A predictive phosphorylation signature of lung cancer (Q28472058) (← links)
- Drug Discovery Using Chemical Systems Biology: Weak Inhibition of Multiple Kinases May Contribute to the Anti-Cancer Effect of Nelfinavir (Q28477930) (← links)
- Multi-target drugs: the trend of drug research and development (Q28480888) (← links)
- The use of functional chemical-protein associations to identify multi-pathway renoprotectants (Q28538871) (← links)
- Induction of Apoptosis in MCF-7 Cells via Oxidative Stress Generation, Mitochondria-Dependent and Caspase-Independent Pathway by Ethyl Acetate Extract of Dillenia suffruticosa and Its Chemical Profile (Q28547953) (← links)
- Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG) (Q28548416) (← links)
- Disrupting the networks of cancer (Q28656016) (← links)
- BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity. (Q30370399) (← links)
- BioGPS: The Music for the Chemo- and Bioinformatics Walzer (Q30391391) (← links)
- Identification of repurposed small molecule drugs for chordoma therapy. (Q30417586) (← links)
- Strategic protein target analysis for developing drugs to stop dental caries (Q30420409) (← links)
- Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives (Q30570945) (← links)
- Local and global modes of drug action in biochemical networks (Q33427643) (← links)
- A network-based biomarker approach for molecular investigation and diagnosis of lung cancer (Q33787452) (← links)
- CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells (Q33864755) (← links)
- Cross-Reactivity Virtual Profiling of the Human Kinome by X-ReactKIN: A Chemical Systems Biology Approach (Q34384664) (← links)
- Development and strategies of VEGFR-2/KDR inhibitors (Q34436101) (← links)
- Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer (Q34909902) (← links)
- Silencing of doublecortin-like (DCL) results in decreased mitochondrial activity and delayed neuroblastoma tumor growth (Q35005945) (← links)
- The changing role of pathology in breast cancer diagnosis and treatment (Q35082260) (← links)
- Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients (Q35154233) (← links)
- Targeting invadopodia to block breast cancer metastasis (Q35640216) (← links)
- BRD4 Structure-Activity Relationships of Dual PLK1 Kinase/BRD4 Bromodomain Inhibitor BI-2536 (Q35697342) (← links)
- Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition (Q35753503) (← links)
- 2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib. (Q35786901) (← links)
- Dual Inhibitors Against Topoisomerases and Histone Deacetylases (Q35821010) (← links)
- Unbiased Selection of Peptide-Peptoid Hybrids Specific for Lung Cancer Compared to Normal Lung Epithelial Cells (Q35824207) (← links)
- An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum (Q35861261) (← links)
- Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods (Q35872435) (← links)
- Multi-target pharmacology: possibilities and limitations of the "skeleton key approach" from a medicinal chemist perspective (Q36097620) (← links)
- Targeting angiogenesis in metastatic breast cancer (Q36182795) (← links)
- The use of novel selectivity metrics in kinase research (Q36240657) (← links)
- Drug repositioning for personalized medicine. (Q36245193) (← links)
- Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches (Q36247419) (← links)
- Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily. (Q36280842) (← links)
- Molecular docking studies of 3-bromopyruvate and its derivatives to metabolic regulatory enzymes: Implication in designing of novel anticancer therapeutic strategies (Q36360728) (← links)
- Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells (Q36946655) (← links)
- Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis (Q36952837) (← links)
- Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability (Q37076842) (← links)
- Dual-functional abeo-taxane derivatives destabilizing microtubule equilibrium and inhibiting NF-κB activation (Q37127718) (← links)
- Kava, a tonic for relieving the irrational development of natural preventive agents (Q37175348) (← links)
- Lapatinib and ixabepilone for the treatment of metastatic breast cancer (Q37281586) (← links)
- CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology (Q37426159) (← links)
- Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase (Q37437242) (← links)